Chih-Yang Hsu1, Yimei Li2, Yuanyuan Han2, Lucas Elijovich3, Noah D Sabin4, Tarek Abuelem5, Radmehr Torabi5, Austin Faught1, Chia-Ho Hua1, Paul Klimo5, Thomas E Merchant1, John T Lucas1. 1. Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA (Work Origin). 2. Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. 3. Vascular Anomalies Center, Le Bonheur Children's Hospital, Memphis, Tennessee, USA. 4. Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. 5. Semmes Murphey, Memphis, Tennessee, USA.
Abstract
BACKGROUND: Cerebral vessel diameter changes objectively and automatically derived from longitudinal magnetic resonance angiography (MRA) facilitate quantification of vessel changes and further modeling. PURPOSE: To characterize longitudinal changes in intracranial vessel diameter using time-of-flight (TOF) MRA. STUDY TYPE: Retrospective longitudinal study. SUBJECT POPULATION: IN all, 112 pediatric patients, aged 9.96 ± 4.59 years, with craniopharyngioma from 2006-2011 scanned annually. FIELD STRENGTH/SEQUENCE: 1.5T and 3T TOF MRA. STATISTICAL TESTS: Chi-square and Wilcoxon-Mann-Whitney tests. ASSESSMENT: Manual measurements using interventional angiography was established as a reference standard for diameter measurements. Constant and linear quantile regression with absolute difference, percentage difference, and relative difference was used for outlier detection. RESULTS: Major vessels surrounding the circle of Willis were successfully segmented except for posterior communicating arteries, mostly due to disease-related hypoplasia. Diameter measurements were calculated at 1-mm segments with a median computed vessel diameter of 1.25 mm. Diameter distortion due to registration was within 0.04 mm for 99% of vessel segments. Outlier detection using quantile regression detected less than 4.34% as being outliers. Outliers were more frequent in smaller vessels and proximity to bifurcations (P < 0.001). DATA CONCLUSION: Using the proposed method, objective changes in vessel diameter can be acquired noninvasively from routine longitudinal imaging. High-throughput analyses of imaging-derived vascular trees combined with clinical and treatment parameters will allow rigorous modeling of vessel diameter changes. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;50:1063-1074.
BACKGROUND: Cerebral vessel diameter changes objectively and automatically derived from longitudinal magnetic resonance angiography (MRA) facilitate quantification of vessel changes and further modeling. PURPOSE: To characterize longitudinal changes in intracranial vessel diameter using time-of-flight (TOF) MRA. STUDY TYPE: Retrospective longitudinal study. SUBJECT POPULATION: IN all, 112 pediatric patients, aged 9.96 ± 4.59 years, with craniopharyngioma from 2006-2011 scanned annually. FIELD STRENGTH/SEQUENCE: 1.5T and 3T TOF MRA. STATISTICAL TESTS: Chi-square and Wilcoxon-Mann-Whitney tests. ASSESSMENT: Manual measurements using interventional angiography was established as a reference standard for diameter measurements. Constant and linear quantile regression with absolute difference, percentage difference, and relative difference was used for outlier detection. RESULTS: Major vessels surrounding the circle of Willis were successfully segmented except for posterior communicating arteries, mostly due to disease-related hypoplasia. Diameter measurements were calculated at 1-mm segments with a median computed vessel diameter of 1.25 mm. Diameter distortion due to registration was within 0.04 mm for 99% of vessel segments. Outlier detection using quantile regression detected less than 4.34% as being outliers. Outliers were more frequent in smaller vessels and proximity to bifurcations (P < 0.001). DATA CONCLUSION: Using the proposed method, objective changes in vessel diameter can be acquired noninvasively from routine longitudinal imaging. High-throughput analyses of imaging-derived vascular trees combined with clinical and treatment parameters will allow rigorous modeling of vessel diameter changes. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;50:1063-1074.
Authors: Mark J Alberts; Richard E Latchaw; Warren R Selman; Timothy Shephard; Mark N Hadley; Lawrence M Brass; Walter Koroshetz; John R Marler; John Booss; Richard D Zorowitz; Janet B Croft; Ellen Magnis; Diane Mulligan; Andrew Jagoda; Robert O'Connor; C Michael Cawley; J J Connors; Jean A Rose-DeRenzy; Marian Emr; Margo Warren; Michael D Walker Journal: Stroke Date: 2005-06-16 Impact factor: 7.914
Authors: N J Ullrich; R Robertson; D D Kinnamon; R M Scott; M W Kieran; C D Turner; S N Chi; L Goumnerova; M Proctor; N J Tarbell; K J Marcus; S L Pomeroy Journal: Neurology Date: 2007-03-20 Impact factor: 9.910
Authors: Li Chen; Mahmud Mossa-Basha; Niranjan Balu; Gador Canton; Jie Sun; Kristi Pimentel; Thomas S Hatsukami; Jenq-Neng Hwang; Chun Yuan Journal: Magn Reson Med Date: 2017-10-17 Impact factor: 4.668
Authors: Saskia Bollmann; Hendrik Mattern; Michaël Bernier; Simon D Robinson; Daniel Park; Oliver Speck; Jonathan R Polimeni Journal: Elife Date: 2022-04-29 Impact factor: 8.713